Intelligent Bio Solutions Statistics
Total Valuation
INBS has a market cap or net worth of $8.41 million. The enterprise value is $6.12 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, before market open.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INBS has 6.78 million shares outstanding. The number of shares has increased by 398.83% in one year.
| Current Share Class | 6.78M |
| Shares Outstanding | 6.78M |
| Shares Change (YoY) | +398.83% |
| Shares Change (QoQ) | +27.25% |
| Owned by Insiders (%) | 1.40% |
| Owned by Institutions (%) | 8.12% |
| Float | 6.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.81 |
| Forward PS | 0.46 |
| PB Ratio | 1.65 |
| P/TBV Ratio | 6.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.10.
| Current Ratio | 1.12 |
| Quick Ratio | 0.84 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -98.26 |
Financial Efficiency
Return on equity (ROE) is -129.19% and return on invested capital (ROIC) is -74.45%.
| Return on Equity (ROE) | -129.19% |
| Return on Assets (ROA) | -48.62% |
| Return on Invested Capital (ROIC) | -74.45% |
| Return on Capital Employed (ROCE) | -206.26% |
| Revenue Per Employee | $58,729 |
| Profits Per Employee | -$205,258 |
| Employee Count | 50 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 1.55 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.95% in the last 52 weeks. The beta is 4.63, so INBS's price volatility has been higher than the market average.
| Beta (5Y) | 4.63 |
| 52-Week Price Change | -48.95% |
| 50-Day Moving Average | 1.54 |
| 200-Day Moving Average | 1.58 |
| Relative Strength Index (RSI) | 43.94 |
| Average Volume (20 Days) | 114,071 |
Short Selling Information
The latest short interest is 533,974, so 7.87% of the outstanding shares have been sold short.
| Short Interest | 533,974 |
| Short Previous Month | 541,819 |
| Short % of Shares Out | 7.87% |
| Short % of Float | 8.80% |
| Short Ratio (days to cover) | 7.43 |
Income Statement
In the last 12 months, INBS had revenue of $2.94 million and -$10.26 million in losses. Loss per share was -$2.40.
| Revenue | 2.94M |
| Gross Profit | 1.73M |
| Operating Income | -10.35M |
| Pretax Income | -10.03M |
| Net Income | -10.26M |
| EBITDA | -9.40M |
| EBIT | -10.35M |
| Loss Per Share | -$2.40 |
Full Income StatementBalance Sheet
The company has $2.81 million in cash and $511,182 in debt, giving a net cash position of $2.30 million or $0.34 per share.
| Cash & Cash Equivalents | 2.81M |
| Total Debt | 511,182 |
| Net Cash | 2.30M |
| Net Cash Per Share | $0.34 |
| Equity (Book Value) | 4.94M |
| Book Value Per Share | 0.75 |
| Working Capital | 542,946 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.41 million and capital expenditures -$190,629, giving a free cash flow of -$10.60 million.
| Operating Cash Flow | -10.41M |
| Capital Expenditures | -190,629 |
| Free Cash Flow | -10.60M |
| FCF Per Share | -$1.56 |
Full Cash Flow StatementMargins
| Gross Margin | 58.81% |
| Operating Margin | -352.62% |
| Pretax Margin | -350.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |